Lunch Program: Targeting Lipids to Improve Outcomes in Your Cath Patients
At the end of this activity, participants will be able to:
- Discuss testing strategies for lipoprotein (a), apoB, and lipid analysis in contemporary practice.
- Recognize system-level gaps and explore system-based strategies to provide optimal guideline directed lipid-lowering therapy for secondary prevention.
- Clarify when to use statins and non-statin therapies to achieve lipid targets.
- Empower patients with knowledge necessary to make decisions about setting and achieving their target lipid levels.
Sponsored by SCAI. Supported by Esperion.